1Institute of Health and Environment, Seoul National University, Seoul, Korea
2Samsung Advanced Institute of Health Science and Technology, Sungkyunkwan University, Seoul, Korea
3Department of Public Health Sciences, Graduate School of Public Health, Seoul National University, Seoul, Korea
Copyright © 2020 The Korean Society for Preventive Medicine
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
CONFLICT OF INTEREST
The authors have no conflicts of interest associated with the material presented in this paper.
FUNDING
This research was funded by the Science & Technology Policy Institute (No. 0409-20200222).
AUTHOR CONTRIBUTIONS
Conceptualization: SJK, JM, HN. Data curation: HK. Formal analysis: JM, HK. Funding acquisition: SIC. Methodology: JM, HN. Project administration: SJK. Visualization: HK. Writing – original draft: SJK, JM, HN. Writing – review & editing: SIC, HK, ST, SJK.
Title and citation | Findings |
---|---|
Non-pharmaceutical measures for pandemic influenza in non-healthcare settings- international travel-related measures (Ryu et al., 2020) [4] | Fifteen studies were included; some stated that travel restrictions could delay local and international spread; One study reported that small Pacific islands prevented pandemic influenza through complete border closure in 1918-19; However, the overall evidence suggests that the effectiveness of international travel-related NPIs for controlling pandemic influenza was limited at, so its implementation needs careful consideration |
An integrated review of the limited evidence on international travel bans as an emerging infectious disease disaster control measure (Errett et al., 2020) [5] | The authors reviewed travel restrictions implemented during the spread of four emerging infectious diseases: SARS, MERS, EVD, and ZVD; They found limited evidence for the effectiveness of travel restrictions; any such effectiveness was only short-term |
Non-pharmaceutical public health measures for mitigating the risk and impact of epidemic and pandemic influenza (WHO, 2019) [6] | Eleven studies of travel restrictions during influenza pandemics in the community setting were analyzed; One study estimated that a 99% restriction of travel between Hong Kong and mainland China delayed the SARS epidemic peak by about 2 weeks; Restricting other modes of transportation, such as land and sea, would have had less impact (2-3 d) on the epidemic peak; Another study reported that the epidemic peak delay (1-3 wk) depended on the transmission rate (1.4, 1.7, or 2.0) and level of restriction (90% or 99%); One global-scale study stated that travel restrictions could delay global spread by 5-133 days |
The WHO report noted that most studies were simulation studies or natural experiments, and that larger trials have never been evaluated; Overall, travel restrictions or border closure may slow the spread of disease, but evidence of the effectiveness of travel restrictions is very low quality and thus highly unreliable | |
Effectiveness of travel restrictions in the rapid containment of human influenza: a systematic review (Mateus et al., 2014) [7] | Studies of the effectiveness of international travel restrictions indicated that specific measures may be more beneficial, such as reducing flight connections rather than widespread restrictions, to import fewer infected travelers; Assessment of the risk of bias indicated a low to moderate risk of bias; In particular, the scarcity of sea and land travel data may lead to overestimation of the impact of air travel bans |
Title and citation | Findings |
---|---|
Non-pharmaceutical measures for pandemic influenza in non-healthcare settings- international travel-related measures (Ryu et al., 2020) [4] | Fifteen studies were included; some stated that travel restrictions could delay local and international spread; One study reported that small Pacific islands prevented pandemic influenza through complete border closure in 1918-19; However, the overall evidence suggests that the effectiveness of international travel-related NPIs for controlling pandemic influenza was limited at, so its implementation needs careful consideration |
An integrated review of the limited evidence on international travel bans as an emerging infectious disease disaster control measure (Errett et al., 2020) [5] | The authors reviewed travel restrictions implemented during the spread of four emerging infectious diseases: SARS, MERS, EVD, and ZVD; They found limited evidence for the effectiveness of travel restrictions; any such effectiveness was only short-term |
Non-pharmaceutical public health measures for mitigating the risk and impact of epidemic and pandemic influenza (WHO, 2019) [6] | Eleven studies of travel restrictions during influenza pandemics in the community setting were analyzed; One study estimated that a 99% restriction of travel between Hong Kong and mainland China delayed the SARS epidemic peak by about 2 weeks; Restricting other modes of transportation, such as land and sea, would have had less impact (2-3 d) on the epidemic peak; Another study reported that the epidemic peak delay (1-3 wk) depended on the transmission rate (1.4, 1.7, or 2.0) and level of restriction (90% or 99%); One global-scale study stated that travel restrictions could delay global spread by 5-133 days |
The WHO report noted that most studies were simulation studies or natural experiments, and that larger trials have never been evaluated; Overall, travel restrictions or border closure may slow the spread of disease, but evidence of the effectiveness of travel restrictions is very low quality and thus highly unreliable | |
Effectiveness of travel restrictions in the rapid containment of human influenza: a systematic review (Mateus et al., 2014) [7] | Studies of the effectiveness of international travel restrictions indicated that specific measures may be more beneficial, such as reducing flight connections rather than widespread restrictions, to import fewer infected travelers; Assessment of the risk of bias indicated a low to moderate risk of bias; In particular, the scarcity of sea and land travel data may lead to overestimation of the impact of air travel bans |
NPIs, non-pharmaceutical interventions; SARS, severe acute respiratory syndrome; MERS, Middle East respiratory syndrome; EVD, Ebola virus disease; ZVD, Zika virus disease; WHO, World Health Organization.